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Many tumors uncouple anabolic glucose utilization from oxygen
availability to sustain unrestrained growth when oxygen and
nutrients are scarce, but the concomitant decrease in mitochondrial
respiration potentially exposes cancer cells to oxidative stress.
However, the mechanistic basis for this metabolic switch, and its
importance in the neoplastic process, has remained unclear. The
mitochondrial molecular chaperone TRAP1 is induced in most tumor
types, where it modulates both mitochondrial respiration and redox
equilibrium of neoplastic cells. TRAP1 binds to and inhibits succinate
dehydrogenase (SDH), the complex II of the respiratory chain. The
ensuing respiratory down-regulation promotes tumor growth by
minimizing oxidative damage, as it abrogates ROS generation by SDH
and the ensuing lethal opening of the mitochondrial permeability
transition pore. Moreover, TRAP1 primes the succinate-dependent
stabilization of the pro-neoplastic transcription factor HIF1. These
ﬁndings provide a mechanistic clue to explain the switch to aerobic
glycolysis of tumors, and indicate that the metabolic changes elicited by
TRAP1 are required for neoplastic growth.
doi:10.1016/j.bbabio.2014.05.002
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Altered mitochondrial bioenergetics, including dysfunction in pyru-
vate dehydrogenase (PDH) and transcriptional deregulation have been
described in Huntington's disease (HD), an autosomal dominant neuro-
degenerative disease. We previously showed that histone deacetylase
inhibitors (HDACis), which regulate transcription, positively inﬂuence
mitochondrial function in cells expressing mutant huntingtin. Thus, we
investigated the effect of the HDACis in PDH dysfunction in striatal cells
derived fromHDknock-inmice andHDYAC128mice brain.Mutant cells
exhibited decreased PDH activity and protein levels of E1alpha subunit
and increased PDH E1alpha phosphorylation/inactivation, which was
accompanied by increased protein expression of PDH kinase (PDK)1
and decreased expression of PDH phosphatase (PDP)1. Exposure to
dichloroacetate, an indirect activator of PDH, increased cell viability and
mitochondrial respiration and decreased production of reactive oxygen
species in mutant cells, emphasizing PDH as an possible therapeutic
target in HD. Treatment with sodium butyrate (SB) and phenylbutyrate,
two HDACis, increased histone H3 acetylation, recovered cell viability
and mitochondrial respiration in mutant cells. Exposure to SB also
increased PDH E1alpha subunit levels and decreased PDH phosphory-
lation in mutant cells, which was associated with decreased gene
expression of the two most abundant PDK isoforms, PDK2 and PDK3. In
accordance, YAC128 mice brain cortex presented higher mRNA levels
of PDK1-3, which were reduced following SB treatment. These results
suggest that HDACis, in particular SB, may promote the expression and
activity of PDH in HD brain, helping to counteract HD-related deﬁcits in
mitochondrial bioenergetics. Supported by Fundação para a Ciência e a
Tecnologia (FCT), Portugal, grant PTDC/SAU-FCF/108056/2008.
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Calcium is thought to regulate respiration but it is unclear whether
this is dependent on the increase in ATP demand caused by any Ca2+
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